CryoCor, Inc. Subject of Lawsuit Relating to Tender Offer ...(intention or obligation to publicly upda...),Health

Date:5/16/2008

intention or obligation to publicly update or revise any forward-looking statements to reflect any change in our expectations or in events, conditions, or circumstances on which those expectations may be based, or that may affect the likelihood that actual results will differ from those contained in the forward-looking statements. This cautionary statement is applicable to all forward-looking statements contained in this document.

Additional Information

Stockholders of CryoCor are urged to read the relevant tender offer documents because they contain important information that stockholders should consider before making any decision regarding tendering their shares. Boston Scientific Corporation, Boston Scientific Scimed, Inc. and its acquisition subsidiary have filed tender offer materials with the SEC, and CryoCor has filed a Solicitation/Recommendation Statement with respect to the tender offer. The tender offer materials (including an Offer to Purchase, a related Letter of Transmittal and certain other offer documents) and the Solicitation/Recommendation Statement contain important information, which should be read carefully before any decision is made with respect to the tender offer. The Offer to Purchase, the related Letter of Transmittal and certain other offer documents, as well as the Solicitation/Recommendation Statement, are available to all stockholders of CryoCor at no expense to them. Stockholders of CryoCor may obtain a free copy of these statements and other documents filed by Boston Scientific Corporation and CryoCor with the SEC at the website maintained by the SEC at http://www.sec.gov . The tender offer statement and related materials, solicitation/recommendation statement, and such other documents may be obtained for free by directing such requests to Investor Relations of CryoCor, Inc., 9717 Pacific Heights Blvd, San Diego, California 92121.

In addition to the tender offer mate
'/>"/>

SOURCE CryoCor, Inc. Copyright©2008 PR Newswire. All rights reserved

0 GOOD

Page: 1 2 3 4
Related medicine news :

1. CryoCath intends to contest patent infringement claim by CryoCor, Inc.
2. Chronic Illness Often a Taboo Subject: Survey
3. Harm of Abstinence-Only Programs in U.S. and Abroad Subject of Panel Discussion at Two Maine College Campuses
4. Arizona State bioethicist says mental illness is subject to biological and sociocultural factors
5. Although Remicade and Humira Are Being Increasingly Prescribed for Crohns Disease and Ulcerative Colitis, Insurers Are Subjecting Both Drugs to Multiple Cost-Control Strategies
6. Nasdaq Hearings Panel Grants TeamStaffs Request for Continued Listing Subject to a Reverse Stock Split
7. Texas Largest Physician Carrier Announces 5th Successive Rate Cut on Anniversary of Lawsuit Reform
8. Detroit Metro Tower Air Traffic Controllers File Lawsuit Alleging Improper Mold Removal and Health Effects
9. Law Offices of Howard G. Smith Announces Class Action Lawsuit Against LCA-Vision Inc.
10. Rulings Send Lawsuits Against State Farm, American Family Back to Court, Hagens Berman Sobol Shapiro Announces
11. Perrigo Confirms Filing for Generic Version of Mucinex(R) and Announcement of Lawsuit by Adams Respiratory